We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Knee Replacement Devices Boost Early Revision Surgery

By HospiMedica International staff writers
Posted on 03 Jan 2012
Patients who undergo the first 15 operations to place a new total knee arthroplasty (TKA) device are more likely to need early revision surgery than patients who were fitted with a prosthesis previously used in the hospital.

Researchers at the National Institute for Health and Welfare (THL; Helsinki, Finland) examined the risk of early revision surgery following the introduction of a new endoprosthesis model for TKA by studying data from the Finnish Arthroplasty Register to identify centers that had performed TKA replacement operations for primary osteoarthritis (OA) between 1998 and 2004. More...
Of the 23,707 patients who underwent the surgical procedure, 22,551 were followed up for five years. The researchers excluded longer follow up from the analysis as subsequent revisions might result from wear rather than early technical failures.

The researchers found that the introduction of an endoprosthesis model in a hospital put the first patients at greater risk of revision surgery. The effect was substantial for the first 15 patients operated on with the new model, who were at 48% greater risk than patients having undergone an operation to implant a conventional endoprosthesis were. Overall, the likelihood of needing revision surgery was greatest during the first two years after the TKA procedure. The learning curve smoothed quickly, however, with no increased risk after the first 15 operations with the new model. The study was published early online on December 9, 2011, in Clinical Orthopaedics and Related Research.

“Patients should be informed if there is a plan to introduce a new model and offered the option to choose a conventional endoprosthesis instead,” concluded lead author Mikko Peltola, PhD, and colleagues of the THL Centre for Health and Social Economics (CHESS). “Although introducing potentially better endoprosthesis models is important, there is a need for managed uptake of new technology.”

TKA is an established treatment for patients with severe OA of the knee. There are numerous brands and models of endoprostheses available, and new models continue to emerge as a result of a combination of new technology, marketing efforts, and the increasing number of patients requiring the surgery. Hospital staff makes important decisions when choosing the implants and instruments they use, and these decisions carry consequences for patients' health.

Related Links:

[Finland] National Institute for Health and Welfare


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.